Skip to main content
KMPHARMACEUTICAL Co.,Ltd. logo

KMPHARMACEUTICAL Co.,Ltd. — Investor Relations & Filings

Ticker · 225430 ISIN · KR7225430008 KO Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2023-03-10 AGM Information
Country KR South Korea
Listing KO 225430

About KMPHARMACEUTICAL Co.,Ltd.

https://en.kmkmp.com/

KMPHARMACEUTICAL Co., Ltd. is a company that develops, manufactures, and distributes personal care products. Its core business areas include oral care solutions, such as toothpaste and toothbrushes; beauty and skincare products; and a dedicated line of items for infants and children. The company leverages its research and development expertise to provide Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, creating customized products tailored to client needs in the oral care and cosmetics sectors. It focuses on developing innovative solutions and adheres to strict quality standards, particularly for its children's product lines.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for KM Pharmaceutical Co., Ltd. It contains the meeting agenda, date, location, and detailed information regarding the board's activities, remuneration, and related party transactions, which are standard components of a proxy statement or notice of meeting. According to the provided definitions, this document serves as the official material sent to shareholders to provide information and request votes for the upcoming meeting, which aligns with the 'Proxy Solicitation & Information Statement' (PSI) category.
2023-03-10 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (KM Pharmaceutical) disclosing a significant change (over 30%) in revenue and profit/loss structure. This is a standard mandatory disclosure filing in the Korean market (DART system) regarding financial performance fluctuations. Since it provides specific financial highlights and reasons for the change rather than just announcing the release of a report, it falls under the 'Earnings Release' category as it serves as the initial announcement of financial results. FY 2022
2023-02-14 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's representative director (CEO). It details the previous and new representatives, the reason for the change, the date of the board resolution, and the professional background of the new appointee. This falls directly under the category of board or management changes.
2023-01-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (pledges) of a major shareholder (Kang Il-mo) in KM Pharmaceutical Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-01-02 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the actual AGM materials or voting results, but rather serves as a formal notice of the procedural steps required for the meeting. Given it is a regulatory notification regarding meeting preparation, it falls under the RNS category.
2022-12-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details the shareholding status of a major shareholder (Kang Il-mo) in KM Pharmaceutical Co., Ltd., specifically noting changes in collateralized stock loans. This type of filing is a standard regulatory requirement for significant shareholders to disclose their holdings and any changes in their equity position or contractual obligations (like pledges/collateral), which falls under the 'Major Shareholding Notification' category.
2022-12-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.